These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25361569)

  • 1. Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
    Sedivy V; Joshi S; Ghaly Y; Mizera R; Zaloudikova M; Brennan S; Novotna J; Herget J; Gurney AM
    Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(1):L48-57. PubMed ID: 25361569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KV7 channels contribute to paracrine, but not metabolic or ischemic, regulation of coronary vascular reactivity in swine.
    Goodwill AG; Fu L; Noblet JN; Casalini ED; Sassoon D; Berwick ZC; Kassab GS; Tune JD; Dick GM
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H693-704. PubMed ID: 26825518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries.
    Mills TA; Greenwood SL; Devlin G; Shweikh Y; Robinson M; Cowley E; Hayward CE; Cottrell EC; Tropea T; Brereton MF; Dalby-Brown W; Wareing M
    Placenta; 2015 Jun; 36(6):638-44. PubMed ID: 25862611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kv7 potassium channel activator flupirtine affects clinical excitability parameters of myelinated axons in isolated rat sural nerve.
    Sittl R; Carr RW; Schwarz JR; Grafe P
    J Peripher Nerv Syst; 2010 Mar; 15(1):63-72. PubMed ID: 20433607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
    Lee S; Yang Y; Tanner MA; Li M; Hill MA
    Microcirculation; 2015 Feb; 22(2):109-121. PubMed ID: 25476662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle.
    Joshi S; Sedivy V; Hodyc D; Herget J; Gurney AM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):368-76. PubMed ID: 19151245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.
    Mackie AR; Brueggemann LI; Henderson KK; Shiels AJ; Cribbs LL; Scrogin KE; Byron KL
    J Pharmacol Exp Ther; 2008 May; 325(2):475-83. PubMed ID: 18272810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
    Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
    Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kv7 channel inhibition increases hypoxic pulmonary vasoconstriction in endotoxemic mouse lungs.
    Turzo M; Spöhr FA; Felix L; Weigand MA; Busch CJ
    Exp Lung Res; 2020 Dec; 46(10):363-375. PubMed ID: 32945215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
    Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR
    Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
    Yeung S; Schwake M; Pucovský V; Greenwood Ia
    Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of KV7 Channels Protects the Rat Heart against Myocardial Ischemia and Reperfusion Injury.
    Hedegaard ER; Johnsen J; Povlsen JA; Jespersen NR; Shanmuganathan JA; Laursen MR; Kristiansen SB; Simonsen U; Bøtker HE
    J Pharmacol Exp Ther; 2016 Apr; 357(1):94-102. PubMed ID: 26869667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
    Mondéjar-Parreño G; Barreira B; Callejo M; Morales-Cano D; Barrese V; Esquivel-Ruiz S; Olivencia MA; Macías M; Moreno L; Greenwood IA; Perez-Vizcaino F; Cogolludo A
    Hypertension; 2020 Oct; 76(4):1134-1146. PubMed ID: 32829658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats.
    Stott JB; Barrese V; Jepps TA; Leighton EV; Greenwood IA
    Hypertension; 2015 Mar; 65(3):676-82. PubMed ID: 25547342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vasoconstrictor action of KCNQ potassium channel blockers.
    Joshi S; Balan P; Gurney AM
    Respir Res; 2006 Feb; 7(1):31. PubMed ID: 16504007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction.
    Zavaritskaya O; Zhuravleva N; Schleifenbaum J; Gloe T; Devermann L; Kluge R; Mladenov M; Frey M; Gagov H; Fésüs G; Gollasch M; Schubert R
    Hypertension; 2013 Jan; 61(1):151-9. PubMed ID: 23184384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels.
    Haick JM; Byron KL
    Pharmacol Ther; 2016 Sep; 165():14-25. PubMed ID: 27179745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
    Moudgil R; Michelakis ED; Archer SL
    Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.
    Cahill E; Rowan SC; Sands M; Banahan M; Ryan D; Howell K; McLoughlin P
    Exp Physiol; 2012 Jun; 97(6):796-806. PubMed ID: 22366565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K
    Bientinesi R; Mancuso C; Martire M; Bassi PF; Sacco E; Currò D
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):127-137. PubMed ID: 27761601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.